In order to assess the value of human cytomegalovirus (HCMV) DNA amplification of gastrointestinal biopsies, we studied 57 human immunodeficiency virus-infected patients with and without gastrointestinal HCMV diseases. After DNA extraction, a 406-bp fragment from the unique short region of the HCMV genome was amplified by 35 cycles of polymerase chain reaction (PCR) and semiquantified from 80 to 80,000 HCMV genomic copies. Among 12 non-AIDS patients, the PCR assay was negative for 11 of 12 duodenal and 8 of 8 colorectal samples. It was also negative for 28 of 31 duodenal and 12 of 15 colorectal samples from 31 AIDS patients without gastrointestinal HCMV diseases. Among 14 AIDS patients with gastrointestinal HCMV diseases, the PCR assay was positive for 12 of 12 patients with HCMV duodenitis and for 13 of 13 patients with HCMV colitis. Results were dichotomized between high and low HCMV-DNA copy numbers. For duodenitis, sensitivity was 92% and specificity was 100%. For colitis, sensitivity was 92% and specificity was 93%. Specificity and sensitivity were not influenced by shedding status for HCMV or by other gastrointestinal infections. HCMV DNA amplification of gastrointestinal biopsies is a sensitive and specific tool for the diagnosis of gastrointestinal HCMV diseases in AIDS patients.
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Human cytomegalovirus (HCMV) diseases are a major cause of morbidity and mortality in patients with AIDS. The most common manifestation of HCMV diseases in these patients is retinitis, but gastrointestinal involvement is reported for 2.2 to 13.1% of AIDS patients (3, 6, 8, 9) and disseminated diseases are found at autopsy in up to 90% of patients (4). Since both standard histology and virus isolation by culture may lack sensitivity (2, 6), the diagnosis of gastrointestinal HCMV diseases from endoscopical biopsies is often difficult. Since the efficacy of antiviral therapy is influenced by early administration, rapid and specific methods may be developed for an early diagnosis. Recent studies have demonstrated the high sensitivity of in situ hybridization for HCMV with gastrointestinal biopsies (1, 10, 15) , but the method is technically complex and cannot be adapted to routine analysis. Detection of HCMV DNA in blood and urine by polymerase chain reaction (PCR) has been previously reported for immunosuppressed and AIDS patients (7, 11) . We have therefore evaluated the diagnostic value of HCMV DNA amplification by PCR of gastrointestinal biopsies obtained from a well-defined population of 57 patients infected with human immunodeficiency virus (HIV) with and without gastrointestinal HCMV diseases. HCMV DNA amplification. On the basis of published sequence data for the AD169 strain (14) and previous studies on restriction site conservation (12) , two 25-base oligonucleotide primers selected in the HindIII-X fragment were synthesized. The primer pair (sequences 5' to 3': upstream primer, GGATCCGCATGGCATTCACGTATGT; downstream primer, GAATTCAGTGGATAACCTGCGGCGA) frame a 406-bp fragment between restriction sites BamHI and EcoRI from the unique short region of the HCMV genome and gave consistantly negative results when assayed with related human herpesvirus DNA (herpes simplex types 1 and 2, Epstein-Barr virus, varicella-zoster virus, and human herpesvirus type 6). For amplification, DNA from fresh biopsies was prepared by RNase and proteinase K digestion, phenol extraction, and ethanol precipitation. After being diluted in 10 mM Tris-1 mM EDTA, DNA was quantitated with a 260-nm spectrophotometer and was adjusted for amplification at an optical density of 1 (Fig. 1) . The +1 and +2 results were defined as low-level HCMV DNA, while the +3 and +4 results were defined as high-level HCMV DNA. In parallel with DNA amplification, conventional viral cultures and shell vial cultures (13) were performed with gastrointestinal biopsies and with blood and urine samples. All specimens were processed blindly with respect to clinical data.
MATERIALS AND METHODS

RESULTS
The major clinical and biological findings in the three groups are summarized in Tables 1 and 2 . The patients' ages ranged from 20 to 61 years, with a mean age of 38 years. Fifty-four patients were male, and 3 were female. The major risk factor for acquiring HIV was male homo-or bisexuality for 44, intravenous drug addiction for 9, and heterosexual transmission for 4 patients.
Control groups 1 and 2: non-AIDS patients and AIDS patients without gastrointestinal HCMV diseases. All of the non-AIDS patients and 28 AIDS patients without gastrointestinal HCMV diseases remained free of HCMV diseases after follow-up 4 months later. One patient presented with HCMV retinitis at the initial examination, and two others developed HCMV retinitis 3 and 4 months, respectively, after endoscopies. PCR was negative for duodenal biopsies from these three patients, while a rectal biopsy revealed low-level HCMV DNA (+1) in one patient. Gastrointestinal symptoms were related to other enteric pathogens in 13 AIDS patients (Cryptosporidium spp. in seven, Giardia intestinalis in two, Entamoeba histolytica in one, Isospora belli in one, Enterocytozoon bieneusi in one, and Mycobac- Group 3: AIDS patients with gastrointestinal HCMV diseases. All 14 patients were male, and all but one were homoor bisexual. They all had previous AIDS-defining conditions before the onset of HCMV diseases. At the onset of gastrointestinal symptoms, six patients had typical HCMV retinitis and three others had evidence of disseminated HCMV diseases and encephalitis. All patients reported severe diarrhea, which was associated with fever above 38.5°C in 11 patients. Two patients subsequently developed peritonitis. Eleven patients had diffuse gastrointestinal HCMV diseases with endoscopical and histological signs of both duodenitis and colitis. One patient presented with isolated duodenitis, while two patients had severe colitis with normal duodena (Fig. 1) and were considered in the AIDS control group (group 2) for the calculation of the specificity of PCR assay for the diagnosis of HCMV duodenitis. The sensitivity of a positive PCR result from duodenal biopsies for the diagnosis of HCMV duodenitis was 100% (12 of 12 biopsies), and the specificity was 88% (29 of 33 biopsies). The sensitivity of a positive PCR result from colorectal biopsies for the diagnosis of HCMV colitis was 100% (13 of 13 biopsies), and the specificity was 80% (12 of 15 biopsies). To increase specificity, PCR results were dichotomized between those with negative and low-level HCMV DNA (negative, +1 and +2 results, corresponding to fewer than 800 HCMV DNA genomic copies) and those with high-level HCMV DNA (+3 and +4 results, corresponding to 8,000 or more HCMV DNA genomic copies). Specificity therefore increased to 100% (33 of 33 biopsies) for duodenitis and to 93% (14 of 15 biopsies) for colitis, while sensitivity decreased to 92% for both duodenitis (11 of 12 biopsies) and colitis (12 of 13 biopsies). (6) . The location of the biopsies may also affect the diagnosis, since preferential cecal involvement has been previously reported in some studies (3, 9) . Immunocytochemical techniques have also demonstrated that typical intranuclear inclusions (Cowdry type A) are far less common than atypical cytopathic effect (6) and can be confused with herpes simplex virus pathological effect. Compared with HCMV isolation from gastrointestinal biop-sies, histology has a sensitivity of 30 to 54% (1, 5) . The sensitivities of both histology and culture are also low (38 to 58 and 55%, respectively) compared with that of in situ hybridization (1, 10, 15) . The diagnosis of gastrointestinal HCMV diseases relies, therefore, on the conjunction of clinical, histological, and virological evidence rather than on the result of a single assay. We have used these criteria to define our study and control groups, and we have therefore studied the value of PCR assay to diagnose gastrointestinal HCMV diseases in these populations. The sensitivity and the specificity of the technique are very high, especially when only the highest levels of HCMV DNA are considered. Factors which could induce false-positive results are the severity of immunodeficiency and the shedding status for HCMV. However, these two factors did not affect sensitivity and specificity in this study. Another parameter which could explain false-positive results is gastrointestinal inflammation caused by other pathogens. In our study, two patients from group 2 with G. intestinalis and I. belli infections presented with low-level HCMV DNA from biopsies. The significance of such results is unclear, since these patients had no evidence of gastrointestinal HCMV diseases during the follow-up visit. However, 11 other AIDS patients with other causes of gastrointestinal inflammation had negative PCR results, suggesting that this phenomenon was of minor importance. The specificity of the assay was also enhanced by a negative result from one patient who presented with HCMV retinitis and no evidence of gastrointestinal HCMV diseases. Similarly, two patients presenting with colitis and normal duodena had high-level HCMV DNA from colorectal biopsies, while duodenal biopsies gave negative or low-level HCMV DNA results. In conclusion, HCMV DNA amplification of gastrointestinal biopsies appears a promising, highly sensitive, and specific tool for the diagnosis of gastrointestinal HCMV diseases. Results may be obtained within a few days, allowing the prompt initiation of antiviral therapy. Further studies are required to assess its value for monitoring antiviral therapy.
